有创测量的主动脉收缩压与诊室收缩压在CKD心血管风险评估中的比较
前瞻性队列研究纳入39,866例接受择期冠状动脉造影的患者,其中17%合并CKD,比较有创测量的主动脉收缩压与诊室收缩压对心梗、卒中和死亡的预测能力。中位随访7.2年,两种血压指标均与部分结局相关,但C统计量显示预测能力无显著差异。结论:无论是否合并CKD,有创中心动脉收缩压并不优于诊室肱动脉血压预测结局。
要点
- 在CKD与非CKD患者中,有创主动脉收缩压与诊室收缩压对结局预测能力无显著差异。
- 诊室与主动脉收缩压均与非CKD患者卒中及CKD患者心梗风险相关。
- CKD显著增加卒中、心梗和死亡风险。
核心结论
- 无论是否合并CKD,有创测量的中心主动脉收缩压相比诊室肱动脉血压并未改善结局预测能力。
研究设计与样本
- 前瞻性纵向队列研究,纳入39,866例接受择期冠状动脉造影的患者,平均年龄64岁,58%为男性,64%有高血压。
- CKD定义为eGFR<60 ml/min per 1.73 m2,共6605例(17%)合并CKD。
- 采用多变量Cox模型分析血压与 incident MI、卒中及死亡的关联,并用C统计量比较预测能力。
主要发现
- 中位随访7.2年(IQR 4.6-10.1年),发生卒中1367例(CKD 353例)、心梗1858例(CKD 446例)、死亡7551例(CKD 2515例)。
- CKD显著增加卒中、心梗和死亡风险。
- 非CKD患者中,诊室与主动脉收缩压均与卒中相关,每10 mmHg的校正HR分别为1.08(95%CI 1.05-1.12)和1.06(95%CI 1.03-1.09)。
- CKD患者中,诊室与主动脉收缩压均与心梗相关,每10 mmHg的校正HR分别为1.08(95%CI 1.03-1.13)和1.08(95%CI 1.04-1.12)。
- 校正模型C统计量比较显示,诊室与主动脉收缩压对结局的预测无显著差异。
临床怎么用
- 在CKD心血管风险评估中,常规诊室肱动脉血压测量已足够,无需依赖有创主动脉收缩压测量来改善风险预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Central aortic blood pressure (BP) could be a better risk predictor than brachial BP. This study examined whether invasively measured aortic systolic BP improved outcome prediction beyond risk prediction by conventional cuff-based office systolic BP in patients with and without chronic kidney disease (CKD). METHODS: In a prospective, longitudinal cohort study, aortic and office systolic BPs were registered in patients undergoing elective coronary angiography (CAG). CKD was defined as estimated glomerular filtration rate (eGFR) <60 ml/min per 1.73 m2. Multivariable Cox models were used to determine the association with incident myocardial infarction (MI), stroke, and death. RESULTS: Aortic and office systolic BPs were available in 39,866 patients (mean age: 64 years; 58% males; 64% with hypertension) out of which 6605 (17%) had CKD. During a median follow-up of 7.2 years (interquartile range: 4.6-10.1 years), 1367 strokes (CKD: 353), 1858 MIs (CKD: 446), and 7551 deaths (CKD: 2515) occurred. CKD increased the risk of stroke, MI, and death significantly. Office and aortic systolic BP were both associated with stroke in non-CKD patients (adjusted hazard ratios with 95% confidence interval per 10 mm Hg: 1.08 [1.05-1.12] and 1.06 [1.03-1.09], respectively) and with MI in patients with CKD (adjusted hazard ratios: 1.08 [1.03-1.13] and 1.08 [1.04-1.12], respectively). There was no significant difference between prediction of outcome with office or aortic systolic BP when adjusted models were compared with C-statistics. CONCLUSION: Regardless of CKD status, invasively measured central aortic systolic BP does not improve the ability to predict outcome compared with brachial office BP measurement.
引用
- Peters CD, Olesen KKW, Laugesen E, et al. Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment in CKD. Kidney Int Rep. 2023. PMID: 38344723. doi:10.1016/j.ekir.2023.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。